Cargando…

When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia

Non-transfusion-dependent thalassaemia (NTDT) refers to all thalassaemia disease phenotypes that do not require regular blood transfusions for survival. Thalassaemia disorders were traditionally concentrated along the tropical belt stretching from sub-Saharan Africa through the Mediterranean region...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taher, A T, Radwan, A, Viprakasit, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302976/ https://www.ncbi.nlm.nih.gov/pubmed/25286743 http://dx.doi.org/10.1111/vox.12201

Ejemplares similares

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition
por: Viprakasit, Vip, et al.
Publicado: (2014)

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia
por: Taher, Ali T, et al.
Publicado: (2023)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
por: Gavriilaki, Eleni, et al.
Publicado: (2018)

Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia
por: Rujito, Lantip, et al.
Publicado: (2015)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

The heart in transfusion dependent homozygous thalassaemia today – prediction, prevention and management
por: Aessopos, Athanassios, et al.
Publicado: (2008)

Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients
por: Ahmed, Azza Mohamed, et al.
Publicado: (2010)

Transfusion trigger: when to transfuse?
por: Marshall, John C
Publicado: (2004)

Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
por: Subahi, Eihab A., et al.
Publicado: (2022)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

Psychiatric disorders and caregiver burden in children with transfusion dependent β-thalassaemia and their caregivers
por: Sahu, Samiksha, et al.
Publicado: (2023)

Prevention of Cardiomyopathy in Transfusion-Dependent Homozygous Thalassaemia Today and the Role of Cardiac Magnetic Resonance Imaging
por: Aessopos, Athanassios, et al.
Publicado: (2009)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka
por: Mettananda, Sachith, et al.
Publicado: (2020)

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report
por: El Afifi, Amal M., et al.
Publicado: (2022)

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K, et al.
Publicado: (2022)

Non-transfusion dependent hemoglobin E/β thalassemia had high prevalence of vitamin D deficiency than more severe patients who received regular blood transfusion and iron chelation therapy
por: Nakavachara, Pairunyar, et al.
Publicado: (2013)

Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan
por: Ahmed Kiani, Rizwan, et al.
Publicado: (2016)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study
por: Medina, Katia Menacho, et al.
Publicado: (2021)

Experiences, Knowledge Gaps and Information Needs of Women in Australia with Transfusion Dependent Thalassaemia in Regard to Fertility and Pregnancy
por: Matthiesson, Hannah K, et al.
Publicado: (2023)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
por: Saliba, Antoine N, et al.
Publicado: (2015)

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox
por: Taher, Ali T, et al.
Publicado: (2014)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
por: Yasara, Nirmani, et al.
Publicado: (2022)

Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study
por: Foong, Wai Cheng, et al.
Publicado: (2022)

Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study
por: Mettananda, Sachith, et al.
Publicado: (2019)

How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023)

Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies
por: Germing, Ulrich, et al.
Publicado: (2019)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients
por: Taher, Ali T, et al.
Publicado: (2013)

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia
por: Caprari, Patrizia, et al.
Publicado: (2023)

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy
por: Barki-Harrington, Liza, et al.
Publicado: (2021)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor
por: Kolnagou, Annita, et al.
Publicado: (2017)

Non-Transfusion-Dependent Thalassemia: A Panoramic Review
por: Shash, Hwazen
Publicado: (2022)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
por: Taher, Ali T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v5hsadp0fg2u7on5e4hjhg6oq9